New study at The James at Ohio State shows promising CLL and NHL treatment option

COLUMBUS, Ohio (WKRC) - Experts at The James have found that a new drug called nemtabrutinib is showing great promise for patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma. Dr. Jennifer Woyach shares what it can mean for patients now and in the future.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is located at 460 W. 10th Ave. on the Ohio State campus. (43210).

To learn more about the OSUCCC – James visit: https://cancer.osu.edu/